Shenzhen Hepalink Pharmaceutical Group (SHEZF) Stock Price, News & Analysis

Company Overview

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is a China-based pharmaceutical company focused on the research, development, manufacturing and sale of heparin-related medicines and pharmaceutical ingredients. Its core business includes heparin sodium and other anticoagulant products used in the prevention and treatment of blood-clotting disorders.

The company supplies active pharmaceutical ingredients and finished pharmaceutical products, with capabilities spanning raw-material processing, quality control and pharmaceutical manufacturing. Its product portfolio has historically included unfractionated heparin and low-molecular-weight heparin products, which are used by healthcare providers and pharmaceutical companies in international markets.

Founded in 1998 and headquartered in Shenzhen, China, Hepalink has developed an international business through exports and overseas operations, serving customers in China and other global markets. The company is publicly listed in China and is also represented in the over-the-counter market in the United States under the symbol SHEZF.

Key Stats

• Today's Range: $0.42 to $0.47
• 50-Day Range: $0.47 to $0.47
• 52-Week Range: $0.47 to $0.47
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: 6.79
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:SHEZF
• CIK: N/A
• Web: www.hepalink.com
• Phone: 86-755-2698-0200
• Fax: N/A
• Employees: 1,926
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 6.79
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A